Flow cytometry analysis of tumors harvested after seven consecutive treatments showed that CEA-TCB treatment induced >10-fold increase in intra-tumor T-cells and >3-fold increase in the intra-tumor CD8/CD4 T-cell ratio (Figures 1B, C, G). Here, CD8A is linked to neoplasm.